Allergan Aesthetics, an AbbVie company, underscored India’s rapid emergence as a key player in the global aesthetic medicine landscape at its sensitization conclave, ‘Aesthetics- Empowering Confidence’. The event brought together leading Aesthetic practitioners like Dr. Sanjeev Nelogi, Dr. Rashmi Shetty, and Dr. Anjali Ghatge, to discuss the transformative potential of aesthetic medical injectables and Allergan Aesthetics’ ongoing commitment to research and education.

The International Society of Aesthetic Plastic Surgery reported that non-surgical procedures outnumbered surgical ones globally in 2020, signaling a growing preference for minimally invasive options. Botulinum toxin remains the most common non-surgical procedure for both men and women and across all age groups, with more than 9 million procedures performed by plastic surgeons worldwide and a 26.1% increase. In second place, hyaluronic acid procedures decreased to 4.3 million. Women currently represent the primary demographic for aesthetic procedures, constituting 85.7% of the market. However, a growing acceptance of aesthetic treatments among men and millennials is reshaping the industry, indicating a more inclusive consumer base.

Spokesperson of Allergan Aesthetics said “India holds immense potential to become a global leader in aesthetic medicine in the coming decades. Research reports highlight that procedures that were once kept secret are now becoming cultural mainstays and we have been at the forefront of the conversation. The pandemic brought a greater focus on wellness and self-care which was an important shift for consumers. We aim to drive growth and innovation in India’s aesthetic medicine market to make aesthetic treatment accessible and beneficial to a wider population.”

While speaking at the conclave, Dr. Rashmi Shetty said, ” People often hesitate to try something new, but now aesthetic medicine, like lip fillers, is as simple as picking up lipstick from the market. These treatments bring psychological well-being to people. It’s never ‘ Botulinum or fillers,’ but ‘ Botulinum toxin fillers,’ as both complement and enhance each other. People must choose their healthcare provider wisely, ensure they use legitimate products, and not be scared of needles—this is the smallest needle used in medical science.”

India’s aesthetic medicine market is experiencing unprecedented growth, driven by a confluence of factors including rising disposable incomes, increasing health consciousness, and rapid urbanization. Industry projections estimate the market to reach a substantial USD 3.02 billion by 2029. This surge in demand has created fertile ground for innovation and advancements in the field.

Dr. Anjali Ghatge said, “Aesthetic medicine goes beyond treating the skin; it’s about enhancing psychological well-being and making patients feel confident in their skin. Our innovative treatments include AI-based facial analysis and body contouring, electromagnetic muscle stimulation, and injectables like dermal fillers and botulinum toxin. We offer personalized, tailor-made approaches for each patient, addressing needs from bone to muscle to skin. Each treatment plan is unique and custom-made, ensuring a comfortable and confident experience for every individual.”

Further, Dr. Sanjeev Nelogi added, “The trends have changed now. Anybody who wants to be more confident in their appearance is choosing professional aesthetic treatment. While once it was believed that such treatments are for film stars and celebrities, now we see an upward trend in common people choosing the aesthetic route.”

Allergan Aesthetics reaffirmed its commitment to driving education, innovation, and responsible practices within the aesthetic medicine industry. The company emphasized the importance of fostering strong partnerships between healthcare providers, industry stakeholders, and regulatory bodies to ensure patient safety, ethical standards, and standardized procedure